News
01-22-2016, 01:23 AM
UT Southwestern Medical Center researchers have found that cancer drugs known as CDK4/6-inhibitors alter the metabolism of pancreatic cancer cells, revealing a biologic vulnerability that could be exploited for therapeutic gain.
More... (http://www.news-medical.net/news/20160122/UT-Southwestern-researchers-reveal-how-CDK46-inhibitors-alter-pancreatic-cancer-cell-metabolism.aspx)
More... (http://www.news-medical.net/news/20160122/UT-Southwestern-researchers-reveal-how-CDK46-inhibitors-alter-pancreatic-cancer-cell-metabolism.aspx)